LICITRA, LISA FRANCESCA LINDA
LICITRA, LISA FRANCESCA LINDA
Dipartimento di Oncologia ed Emato-Oncologia
MRI radiomics in head and neck cancer from reproducibility to combined approaches
2024 A. Corti, S. Cavalieri, G. Calareso, D. Mattavelli, M. Ravanelli, T. Poli, L. Licitra, V. Corino, L. Mainardi
Quality of life in head and neck cancer survivors: the Big Data for Quality of Life study
2024 M. Moreira-Soares, E. Fossen, K. Taylor, S. Singer, K. Hurley, S. Thomas, M. Pring, A. Ness, S. Cavalieri, C. Vener, L. Lopez-Perez, M. Cabrera-Umpierrez, G. Fico, A. Frigessi, L. Licitra, M. Leblanc
Hedgehog inhibitors beyond clinical complete response in basal cell carcinoma: should I stop or should I go?
2024 S. Alfieri, R. Romanò, S. Marceglia, V. De Giorgi, K. Peris, P. Sollena, A. Piccerillo, R. Moro, G. Gualdi, P. Ascierto, M. Palla, M. Paone, L. Eibenschutz, F. Spagnolo, P. Queirolo, D. Filippini, S. Cavalieri, C. Resteghini, C. Bergamini, A. Manocchio, L. Licitra, P. Bossi
Association of a gene-expression subtype to outcome and treatment response in patients with recurrent/ metastatic head and neck squamous cell carcinoma treated with nivolumab
2024 M.S. Serafini, S. Cavalieri, L. Licitra, F. Pistore, D. Lenoci, S. Canevari, M. Airoldi, M.C. Rocca, P. Strojan, C.G. Kuhar, M. Merlano, F. Perrone, A. Vingiani, N. Denaro, F. Perri, A. Argiris, C. Gurizzan, M.G. Ghi, A. Cassano, G. Allegrini, P. Bossi, L. De Cecco
HeNeCOn: An ontology for integrative research in Head and Neck cancer
2024 L. Hernández, E. Estévez-Priego, L. López-Pérez, M. Cabrera-Umpiérrez, M. Arredondo, G. Fico, T. Poli, S. Rossi, E. Martinelli, L. Licitra, S. Cavalieri, L. De Cecco, S. Canevari, K. Scheckenbach, R. Brakenhoff, I. Nauta, F. Hoebers, F. Wesseling, A. Trama, G. Gatta
Claudin-1 in Head and Neck Squamous Cell Carcinoma
2024 S. Cavalieri, C. Bergamini, D. Lenoci, A. Ottini, M. Lucchetta, E. Torchia, L. Licitra, L. De Cecco
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities
2024 D. Lenoci, C. Resteghini, M.S. Serafini, F. Pistore, S. Canevari, B. Ma, S. Cavalieri, S. Alfieri, A. Trama, L. Licitra, L. De Cecco
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma
2023 E. Ho, L. De Cecco, S. Cavalieri, G. Sedor, F. Hoebers, R. Brakenhoff, K. Scheckenbach, T. Poli, K. Yang, J. Scarborough, S. Campbell, S. Koyfman, S. Eschrich, J. Caudell, M. Kattan, L. Licitra, J. Torres-Roca, J. Scott
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
2023 S. Cavalieri, I. Nuzzolese, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, S. Alfieri, P. Quattrone, G. Calareso, N.A. Iacovelli, M. Franceschini, L. Licitra
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol
2023 S. Cavalieri, C. Vener, M. Leblanc, L. Lopez-Perez, G. Fico, C. Resteghini, D. Monzani, G. Marton, G. Pravettoni, M. Moreira-Soares, D.E. Filippidou, A. Almeida, A. Bilbao, H. Mehanna, S. Singer, S. Thomas, L. Lacerenza, A. Manfuso, C. Copelli, F. Mercalli, A. Frigessi, E. Martinelli, L. Licitra
Dietary intervention for tertiary prevention in head and neck squamous cell carcinoma survivors: clinical and translational results of a randomized phase II trial
2023 S. Cavalieri, E. Bruno, M.S. Serafini, D. Lenoci, S. Canevari, L. Lopez-Perez, L. Hernandez, L. Mariani, R. Miceli, C. Gavazzi, P. Pasanisi, E. Rosso, F. Cordero, P. Bossi, W. Golusinski, A. Dietz, P. Strojan, T. Fuereder, L. De Cecco, L. Licitra
Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI dataset
2023 M. Bologna, V. Corino, S. Cavalieri, G. Calareso, S.E. Gazzani, T. Poli, M. Ravanelli, D. Mattavelli, P. de Graaf, I. Nauta, K. Scheckenbach, L. Licitra, L. Mainardi
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures
2023 A. Corti, L. De Cecco, S. Cavalieri, D. Lenoci, F. Pistore, G. Calareso, D. Mattavelli, P. de Graaf, C.R. Leemans, R.H. Brakenhoff, M. Ravanelli, T. Poli, L. Licitra, V. Corino, L. Mainardi
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience
2023 S. Cavalieri, F. Platini, F. Barretta, I. Nuzzolese, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, N.A. Iacovelli, M. Franceschini, G. Calareso, P. Di Pede, G. De Feo, M. Gandelli, L. Toffolatti, M. Guglielmo, C.I. Ripamonti, L. Cosmai, L. Licitra, S. Alfieri
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours
2023 P. Bossi, E. Orlandi, C. Resteghini, B. Vischioni, P. Nicolai, P. Castelnuovo, S. Gambazza, L.D. Locati, M. Turri-Zanoni, M. Ferrari, N. Facchinetti, N.A. Iacovelli, G. Calareso, P. Quattrone, A. Cavallo, A. Tuzi, L. Licitra
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours
2023 C. Resteghini, P. Castelnuovo, P. Nicolai, E. Orlandi, P. Bossi, B. Vischioni, A. Schreiber, S. Gambazza, N.A. Iacovelli, P. Battaglia, M. Guzzo, M. Turri-Zanoni, D. Mattavelli, N. Facchinetti, G. Calareso, M. Ravanelli, C. Facco, T. Tartaro, L. Licitra
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers
2023 A. Trama, L. Licitra, S. Cavalieri, S. Bonfarnuzzo, P. Baili, A. Ciarfella, P. Parente, G. Almadori, M. Ansarin, A. Bacigalupo, P. Baumeister, B. Baujat, P. Bossi, E. Cavalera, M.C. Cercato, F. Dieleman, N. Fakhry, V. Ferraresi, F. Gaino, D. Galizia, J. Halamkova, E. Halme, J. Hardillo, B. Hofauer, E. Kinloch, L. Livi, L.D. Locati, S. Mattheis, G. Mercante, A. Mirabile, G. Molteni, E. Orlandi, R. Persio, S. Sciallero, L. Smeele, M. Tagliabue, V. Valentini, C. Van Harpen, C.B. Westphalen, L. Botta
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC)
2023 S. Cavalieri, V. Vitolo, A. Barcellini, S. Ronchi, A. Facoetti, C. Campo, C. Klersy, S. Molinelli, F. Agustoni, V.V. Ferretti, A. Silvestri, M. Platania, M.D. Vecchio, M. Durante, A. Helm, C. Fournier, F. Braud, P. Pedrazzoli, E. Orlandi, L. Licitra
Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure
2023 L. Botta, T. Matsuda, H. Charvat, C. Chiang, W. Lee, A. van Gestel, F. Martin, G. Geleijnse, M. Cellamare, S. Bonfarnuzzo, R. Marcos-Gragera, M. Guevara, M. Mousavi, S. Craig, J. Rodrigues, J. Rubió-Casadevall, L. Licitra, S. Cavalieri, C. Resteghini, G. Gatta, A. Trama, G. RARECAREnet working
Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients
2023 C. Bergamini, S. Cavalieri, C. Resteghini, S. Alfieri, I. Nuzzolese, E. Colombo, A. Ottini, G. Calareso, A. Vingiani, N.A. Iacovelli, M. Franceschini, M. Guzzo, A. Deganello, L. Licitra